Breakthrough Therapeutics for CLL and Other B-Cell Malignancies: Focus on BTK Inhibitors From Development to Clinical Integration

Download All
Learn from expert faculty as they discuss recent and emerging data in chronic lymphocytic leukemia and mantle cell lymphoma, including a downloadable slideset from a satellite symposium and an on-demand webcast.
Jeff Sharman, MD
Program Director
Ian W. Flinn, MD, PhD
Susan M. O'Brien, MD

Slidesets

Download these slides from an expert-led symposium on the use of BTK inhibitors in the frontline treatment of CLL/SLL.

Susan M. O'Brien, MD Released: December 9, 2022

Download these slides from an expert-led symposium on the use of BTK inhibitors in relapsed/refractory CLL/SLL.

Jeff Sharman, MD
Program Director
Released: December 9, 2022

Download these slides from an expert-led symposium on BTK inhibitors for the treatment of mantle cell lymphoma.

Ian W. Flinn, MD, PhD Released: December 9, 2022

Download these slides from an expert-led symposium on current and emerging BTK inhibitors for chronic lymphocytic leukemia/small lymphocytic lymphoma and mantle cell lymphoma.

Ian W. Flinn, MD, PhD Released: December 9, 2022

Download this short summary slideset of key takeaways from a live symposium on BTK inhibitors in CLL and MCL.

Jeff Sharman, MD
Program Director
Ian W. Flinn, MD, PhD Susan M. O'Brien, MD
Released: December 16, 2022

Webcast

Watch this on-demand webcast from an ASH satellite symposium on the use of novel BTK inhibitors for patients with CLL and MCL, including discussions on current and emerging BTK inhibitors and combinations, treatment for frontline and relapsed/refractory CLL/SLL and MCL, toxicity management, and ongoing clinical trials.

Jeff Sharman, MD
Program Director
Ian W. Flinn, MD, PhD Susan M. O'Brien, MD
Physicians: maximum of 2.0 AMA PRA Category 1 Credits Released: January 31, 2023 Expired: January 30, 2024
Provided by Clinical Care Options, LLC.

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by educational grants from
BeiGene, Ltd.
Lilly

For further information concerning Lilly grant funding visit www.lillygrantoffice.com.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings